首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Prophylactic penehyclidine inhalation for prevention of postoperative pulmonary complications in high-risk patients: study protocol of a randomized controlled trial
【2h】

Prophylactic penehyclidine inhalation for prevention of postoperative pulmonary complications in high-risk patients: study protocol of a randomized controlled trial

机译:预防性戊乙奎醚吸入预防高危患者的术后肺部并发症:一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPostoperative pulmonary complications (PPCs) are major causes of morbidity, mortality, and prolonged hospital stay in patients after surgery. Using effective strategies to prevent its occurrence is essential to improve outcome. However, despite various efforts, the incidence of PPCs remains elevated in high-risk patients. Anticholinergic inhalation is used to reduce high airway resistance and improve pulmonary function; it may be helpful to decrease the risk of PPCs. Penehyclidine is a long-acting anticholinergic agent which selectively blocks M1 and M3 receptors. We hypothesize that, in high-risk patients, prophylactic penehyclidine inhalation may decrease the incidence of PPCs.
机译:背景术后肺部并发症(PPC)是术后患者发病率,死亡率和长时间住院的主要原因。使用有效的策略来防止其发生对于改善结果至关重要。然而,尽管作出了种种努力,但高危患者的PPC发生率仍然很高。吸入抗胆碱能可减少高气道阻力并改善肺功能;降低PPC的风险可能会有所帮助。苯乙奎啶是一种长效抗胆碱能药,可选择性阻断M1和M3受体。我们假设,在高危患者中,预防性戊乙奎醚吸入可能会降低PPC的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号